MPN Advocates Network invite you to their upcoming webinar in collaboration with Kartos Therapeutics, featuring Dr. Serge Verstovsek, Kartos’ Chief Medical Officer.
During this session, Dr. Verstovsek will provide insights into the POIESIS trial, a new and uniquely designed global Phase 3 study for patients with myelofibrosis.
The study will run in 221 hospitals in the USA, Europe and Asia-Pacific.
🗓 Date: Monday, 31 March 2025
⏰ Time: 6:00 PM CET (5 pm BST)
📍 Zoom Webinar
This is a great opportunity to learn more about this cutting-edge clinical trial and its potential impact on myelofibrosis treatment. If you require any further information about this webinar please contact: Marija Stefkova, MPN AN doneva@mpn-advocates.net
